104 related articles for article (PubMed ID: 10561176)
1. Dose-intensive therapy for limited-stage small-cell lung cancer: long-term outcome.
Elias A; Ibrahim J; Skarin AT; Wheeler C; McCauley M; Ayash L; Richardson P; Schnipper L; Antman KH; Frei E
J Clin Oncol; 1999 Apr; 17(4):1175. PubMed ID: 10561176
[TBL] [Abstract][Full Text] [Related]
2. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.
Elias AD; Skarin AT; Richardson P; Ibrahim J; McCauley M; Frei E
Biol Blood Marrow Transplant; 2002; 8(6):326-33. PubMed ID: 12108918
[TBL] [Abstract][Full Text] [Related]
3. Intensive combined modality therapy for limited-stage small-cell lung cancer.
Elias AD; Ayash L; Frei E; Skarin AT; Hunt M; Wheeler C; Schwartz G; Mazanet R; Tepler I; Eder JP
J Natl Cancer Inst; 1993 Apr; 85(7):559-66. PubMed ID: 8384264
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of irinotecan plus cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide plus cisplatin chemotherapy for limited-disease small-cell lung cancer.
Han JY; Cho KH; Lee DH; Kim HY; Kim EA; Lee SY; Lee JS
J Clin Oncol; 2005 May; 23(15):3488-94. PubMed ID: 15908658
[TBL] [Abstract][Full Text] [Related]
5. Multimodality treatment including early high-dose chemotherapy with peripheral blood stem cell transplantation in limited-disease small cell lung cancer.
Brugger W; Fetscher S; Hasse J; Frommhold H; Pressler K; Mertelsmann R; Engelhardt R; Kanz L
Semin Oncol; 1998 Feb; 25(1 Suppl 2):42-8. PubMed ID: 9535211
[TBL] [Abstract][Full Text] [Related]
6. Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study.
Aisner J; Goutsou M; Maurer LH; Cooper R; Chahinian P; Carey R; Skarin A; Slawson R; Perry MC; Green MR
J Clin Oncol; 1992 Aug; 10(8):1230-6. PubMed ID: 1321892
[TBL] [Abstract][Full Text] [Related]
7. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
[TBL] [Abstract][Full Text] [Related]
8. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.
Bessho A; Ueoka H; Kiura K; Tabata M; Sunami K; Katayama Y; Yamane H; Hiraki A; Harada M
Anticancer Res; 1999; 19(1B):693-8. PubMed ID: 10216478
[TBL] [Abstract][Full Text] [Related]
9. Dose-intensive therapy in lung cancer.
Elias A
Cancer Chemother Pharmacol; 1997; 40 Suppl():S64-9. PubMed ID: 9272137
[TBL] [Abstract][Full Text] [Related]
10. Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer.
Ihde DC; Deisseroth AB; Lichter AS; Bunn PA; Carney DN; Cohen MH; Veach SR; Makuch RW; Johnston-Early A; Abrams RA
J Clin Oncol; 1986 Oct; 4(10):1443-54. PubMed ID: 3020181
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study.
Gregor A; Drings P; Burghouts J; Postmus PE; Morgan D; Sahmoud T; Kirkpatrick A; Dalesio O; Giaccone G
J Clin Oncol; 1997 Aug; 15(8):2840-9. PubMed ID: 9256127
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
[TBL] [Abstract][Full Text] [Related]
14. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of irinotecan plus cisplatin with concurrent radiotherapy for the patients with limited-disease small-cell lung cancer.
Jeong HC; Lee SY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
Lung Cancer; 2006 Sep; 53(3):361-6. PubMed ID: 16846662
[TBL] [Abstract][Full Text] [Related]
16. High-dose combined alkylating agent therapy with autologous stem cell support and chest radiotherapy for limited small-cell lung cancer.
Elias AD; Ayash L; Skarin AT; Wheeler C; Schwartz G; Mazanet R; Tepler I; Schnipper L; Frei E; Antman KH
Chest; 1993 Apr; 103(4 Suppl):433S-435S. PubMed ID: 8096454
[TBL] [Abstract][Full Text] [Related]
17. Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group.
Johnson DH; Turrisi AT; Chang AY; Blum R; Bonomi P; Ettinger D; Wagner H
J Clin Oncol; 1993 May; 11(5):879-84. PubMed ID: 8387577
[TBL] [Abstract][Full Text] [Related]
18. Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study.
Humblet Y; Symann M; Bosly A; Delaunois L; Francis C; Machiels J; Beauduin M; Doyen C; Weynants P; Longueville J
J Clin Oncol; 1987 Dec; 5(12):1864-73. PubMed ID: 2824708
[TBL] [Abstract][Full Text] [Related]
19. Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).
Schild SE; Bonner JA; Hillman S; Kozelsky TF; Vigliotti AP; Marks RS; Graham DL; Soori GS; Kugler JW; Tenglin RC; Wender DB; Adjei A
J Clin Oncol; 2007 Jul; 25(21):3124-9. PubMed ID: 17634491
[TBL] [Abstract][Full Text] [Related]
20. Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trial.
Sorensen M; Lassen U; Palshof T; Jensen BB; Johansen J; Jensen PB; Langer SW
Lung Cancer; 2008 May; 60(2):252-8. PubMed ID: 18036701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]